Insider Transactions in Q4 2023 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2023
|
Michael G Grey Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
58,031
-100.0%
|
$6,731,596
$116.5 P/Share
|
|
Oct 06
2023
|
Michael G Grey Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,361
-100.0%
|
$4,565,876
$116.5 P/Share
|
|
Oct 06
2023
|
Pascale Witz Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
20,279
-100.0%
|
$2,352,364
$116.5 P/Share
|
|
Oct 06
2023
|
Pascale Witz Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,672
-100.0%
|
$2,977,952
$116.5 P/Share
|
|
Oct 06
2023
|
Susan Mahony Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
9,306
-100.0%
|
$1,079,496
$116.5 P/Share
|
|
Oct 06
2023
|
Susan Mahony Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,345
-100.0%
|
$1,084,020
$116.5 P/Share
|
|
Oct 06
2023
|
Thomas Watkins Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
65,953
-100.0%
|
$7,650,548
$116.5 P/Share
|
|
Oct 06
2023
|
Thomas Watkins Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
110,447
-100.0%
|
$12,811,852
$116.5 P/Share
|
|
Oct 06
2023
|
Jeff Himawan Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
44,482
-100.0%
|
$5,159,912
$116.5 P/Share
|
|
Oct 06
2023
|
Jeff Himawan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44,546
-100.0%
|
$5,167,336
$116.5 P/Share
|
|
Oct 06
2023
|
William F Daniel Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
47,670
-100.0%
|
$5,529,720
$116.5 P/Share
|
|
Oct 06
2023
|
William F Daniel Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,915
-100.0%
|
$3,702,140
$116.5 P/Share
|
|
Oct 06
2023
|
Gino Santini Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
18,655
-100.0%
|
$2,163,980
$116.5 P/Share
|
|
Oct 06
2023
|
Gino Santini Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100,959
-100.0%
|
$11,711,244
$116.5 P/Share
|
|
Oct 06
2023
|
James Samuel Shannon Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
23,638
-100.0%
|
$2,742,008
$116.5 P/Share
|
|
Oct 06
2023
|
James Samuel Shannon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,156
-100.0%
|
$3,846,096
$116.5 P/Share
|
|
Oct 06
2023
|
Patrick Mc Ilvenny Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,874
-100.0%
|
$797,384
$116.5 P/Share
|
|
Oct 06
2023
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,575
-100.0%
|
$1,690,700
$116.5 P/Share
|
|
Oct 06
2023
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
56,338
-100.0%
|
$6,535,208
$116.5 P/Share
|
|
Oct 06
2023
|
Timothy P Walbert Chairman, President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
257,974
-100.0%
|
$29,924,984
$116.5 P/Share
|
|
Oct 06
2023
|
Timothy P Walbert Chairman, President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
616,772
-100.0%
|
$71,545,552
$116.5 P/Share
|
|
Oct 06
2023
|
Aaron Cox EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
556
-100.0%
|
$64,496
$116.5 P/Share
|
|
Oct 06
2023
|
Sean M. Clayton EVP, General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
745
-100.0%
|
$86,420
$116.5 P/Share
|
|
Oct 06
2023
|
Sean M. Clayton EVP, General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,655
-100.0%
|
$887,980
$116.5 P/Share
|
|
Oct 06
2023
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
126,838
-100.0%
|
$14,713,208
$116.5 P/Share
|
|
Oct 06
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
232,104
-100.0%
|
$26,924,064
$116.5 P/Share
|
|
Oct 06
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,655
-100.0%
|
$307,980
$116.5 P/Share
|
|
Oct 02
2023
|
Gino Santini Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,092
+18.61%
|
$346,380
$15.23 P/Share
|